TECHNETIUM TC-99M FERPENTETATE

First approved in 1973

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C14H23N3O10.C6H8O6.Fe.Tc
Molecular Weight	724.222
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TECHNETIUM TC-99M FERPENTETATE

Structure Search

SMILES

[Fe].[99Tc].[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO.OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O

InChI

InChIKey=LDVQRVOHMMYEBK-BNVFFUDCSA-N

InChI=1S/C14H23N3O10.C6H8O6.Fe.Tc/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;7-1-2(8)5-3(9)4(10)6(11)12-5;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);2,5,7-10H,1H2;;/t;2-,5+;;/m.0../s1/i;;;1+1

HIDE SMILES / InChI

Molecular Formula	C6H8O6
Molecular Weight	176.1241
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Molecular Formula	Fe
Molecular Weight	55.845
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C14H23N3O10
Molecular Weight	393.3465
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Tc
Molecular Weight	98.9063
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.hindawi.com/journals/stni/2014/839369/
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401

Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.

Approval Year

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2578
bone problems 43 Sources: https://www.drugs.com/cons/osteolite.html	Diagnostic	Approved 8429	OSTEOLITE Approved Use Unknown Launch Date 2.50992001E11
osteogenesis 43 Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018035s032lbl.pdf	Diagnostic	Approved 8429	DRAXIMAGE MDP-10 Approved Use MDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date 2.80972788E11

PubMed

Title	Date	PubMed
Future of low specific activity molybdenum-99/technetium-99m generator.	2012 Oct	22642420

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:59:13 UTC 2023` Edited by `admin` on `Fri Dec 15 15:59:13 UTC 2023`
Record UNII	007KG0HTO5
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

TECHNETIUM TC-99M FERPENTETATE

Common Name

English

TECHNETIUM TC 99M FERPENTETATE [USP IMPURITY]

Common Name

English

Technetium tc 99m ferpentetate [WHO-DD]

Common Name

English

TECHNETIUM TC 99M FERPENTETATE

Common Name

English

TECHNETIUM TC 99M IRON ASCORBATE PENTETIC ACID COMPLEX

Common Name

English

Code System Code Type Description

ChEMBL

CHEMBL1201411